Abstract The DRY motif, at the junction of transmembrane helix 3 and intracellular loop 2 of G protein-coupled receptors, is highly conserved. Mutations were introduced into the CB 2 cannabinoid receptor to study the role of this motif in CB 2 signaling. D mutations (DRY130^132AAA and D130A) markedly reduced binding of cannabinoid agonists, while no significant reduction was observed with R131A or Y132A. Mutating R (R131A) only partially reduced, and mutating Y (Y132A) more efficiently reduced the cannabinoid-induced inhibition of adenylyl cyclase. Thus, in CB 2 , D130 is involved in agonist binding, whereas Y seems to have a role in receptor downstream signaling.
Introduction
Two subtypes of cannabinoid receptors, CB 1 and CB 2 , have been cloned to date [1, 2] . Both CB 1 and CB 2 are members of the seven transmembrane (TM) domain G protein-coupled receptor (GPCR) superfamily. While CB 1 is mainly present in the central nervous system, the CB 2 receptor has been found to be expressed in immune cells (such as splenic macrophages, monocytes, B-cells and natural killer cells), as well as in tonsil and bone marrow, but not in brain [2, 3] . Moreover, CB 2 -like cannabinoid receptors have recently been found on peripheral nerve terminals [4, 5] . Both CB 1 and CB 2 act via G iao to inhibit adenylyl cyclase (AC) [6^8] . Relatively little is known about the structure of the CB 2 receptor and the molecular interactions involved in its ligand binding and signal transduction.
The DRY motif at the junction of TM3 and the second intracellular loop (ICL2) is highly conserved in most GPCRs ([9^12]; see Fig. 1 ) and is a candidate site for the interaction of the receptor with the associated G protein [12, 13] . The D residue (residue 3.49 in the nomenclature of Ballesteros and Weinstein [14] ) is found in 94% of the rhodopsin-like GPCRs [9] . A few receptors (e.g. rhodopsin, thyroid stimulating hormone receptor, follicle stimulating hormone receptor) were reported to have E instead of D at this site. Thus, this motif has been de¢ned as the E/DRY motif, see [15] . Mutagenesis of this site in various GPCRs (e.g. rhodopsin, GnRH, K 1B -adrenergic and m 1 -muscarinic receptors) revealed that the D3.49 residue has a role in receptor expression [16, 17] , internalization [16, 18] and constitutive receptor activation [15, 19, 20] . However, di¡erent e¡ects were observed with di¡erent receptors. For example, mutations at D3.49 of the K 1B -adrenergic receptor induced constitutive activation of inositol phosphate production [19, 20] , but did not seem to directly a¡ect G protein signaling of the m 1 -muscarinic receptor [17] . The R3.50 (in the nomenclature of Ballesteros and Weinstein) is completely conserved in all GPCRs and appears to a¡ect the receptor interaction with the coupled G proteins [9, 11, 21] . The Y3.51 of this E/DRY motif is found in 79% of the rhodopsin-like GPCRs [9] and is claimed to be involved in m 1 -muscarinic receptor expression [17] and in the internalization of the bradykinin B2 receptor [22, 23] .
In this study, we investigated the role of the DRY motif in ligand binding and signal transduction of the CB 2 cannabinoid receptor. We found that D130 is essential for the capacity of the CB 2 receptor to bind cannabinoid agonists, whereas Y132 has a role in the receptor downstream signaling. 
Materials and methods

Materials
Plasmids
Rabbit AC type V (AC-V) and L-gal cDNAs in the pXMD1 vector [24] were described previously [7, 25] . The human CB 2 cDNA in pCDM8 [2] was kindly provided by Dr. S. Munro (Cambridge, UK).
2.3. Construction of hemagglutinin (HA)-tagged human CB 2 in pcDNA3 The following oligonucleotide primers (P1 and P2) were synthesized and used to amplify (by PCR) an 1100 bp fragment containing the entire human CB 2 coding sequence (using the human CB 2 cDNA in pCDM8 as a template): P1, 5P-GCGGATCCGAGGAATGCTGG-GTG-3P sense primer; P2, 5P-GCGCGGCCGCTCAGCAATCAGA-GAG-3P antisense primer. P1 is homologous to the cDNA sequence at the CB 2 coding start site and was engineered to contain a unique BamHI site (underlined) for in-frame subcloning into a BglII site at the carboxy end of the HA sequence in HA-pcDNA3 [26] . The P2 sequence was designed to introduce a unique NotI site (underlined) for ligation into the multiple cloning site of pcDNA3. The 1100 bp PCR product (following 25 cycles of 1 min denaturation at 92³C, 1 min annealing at 45³C and 1 min extension at 72³C) was digested with BamHI and NotI and cloned into the BglII and NotI sites of HApcDNA3. The DNA sequence was con¢rmed by sequencing at the Weizmann Institute's DNA Sequencing Unit.
Preparation of point mutations in HA-CB 2
Mutations were introduced using the PCR-overlap extension method as previously described [27] . In brief, two general primers were designed for PCR that cover the region in HA-CB 2 where the mutations were planned. The 5P general primer 5P-TAATACGACTCAC-TATAGGG-3P (complementing part of the T7 sequence of pcDNA3) and the 3P general primer 5P-TTGACCTGGTCACTGAGCGTAGT-3P (complementing a coding sequence in CB 2 beyond the mutation) were used in conjunction with internal sense and matching antisense primers that contained the desired mutation. Three PCR reactions were run, the ¢rst two providing the 5P and 3P ends of the mutated fragment, and the third consecutive reaction joining the separate fragments. The ¢nal PCR product was cut with BamHI and BstEII (unique sites, one in the multiple cloning site of pcDNA3 and the other in HA-CB 2 , beyond the area of the mutation), the mutated fragment cloned into HA-CB 2 and the DNA sequences of the various HA-CB 2 mutants con¢rmed.
Transient cell transfection
24 h before transfection, a con£uent 10 cm plate of COS-7 cells in Dulbecco's modi¢ed Eagle's medium (DMEM), supplemented with 5% fetal calf serum, 100 U/ml penicillin and 100 Wg/ml streptomycin in a humidi¢ed atmosphere consisting of 5% CO 2 and 95% air at 37³C, was trypsinized and split into ¢ve 10 cm plates. The cells were transfected, using the DEAE-dextran chloroquine method [28] , with wild-type (wt) HA-CB 2 cDNA (2 Wg/plate) or mutant cDNAs (4 Wg/plate), and where indicated, with AC-V cDNA (1.5 Wg/plate). pXMD1-gal cDNA was used for mock DNA transfection. For binding studies, 72 h after transfection, the COS cells were washed twice with phosphate-bu¡ered saline (PBS), scraped, centrifuged at 3000 rpm for 10 min and the cell pellets stored at 370³C. For AC assay, 48 h after transfection, the COS cells were trypsinized and re-cultured in 24-well plates, and after an additional 24 h, the cells were assayed for AC activity as described below. Transfection e¤ciency was normally in the range of 40^80%, as determined by staining the cells for the activity of transfected L-galactosidase [29] .
AC activity
The assay was performed in triplicate as described previously [7, 8] . In brief, cells cultured in 24-well plates were incubated for 2 h with 0.25 ml/well fresh growth medium containing 5 WCi/ml [2- 3 H]adenine. This medium was replaced with DMEM containing 20 mM HEPES (pH 7.4), and the phosphodiesterase inhibitors RO-20-1724 (0.5 mM) and IBMX (0.5 mM). Cannabinoids diluted in 10 mg/ml FAF^BSA were then added. AC activity was stimulated in the presence or absence of cannabinoids by the addition of 2 WM FS. After 10 min at 37³C, the medium was removed and the reaction terminated by adding to the cell layer 1 ml of 2.5% perchloric acid containing 0.1 mM unlabeled cAMP. Aliquots of 0.9 ml of the acidic extract were neutralized with 100 Wl of 3.8 M KOH and 0.16 M K 2 CO 3 and applied to a two-step column separation procedure [30] . The [ 3 H]cAMP was eluted into scintillation vials and counted. Background levels (cAMP accumulation in the absence of stimulator) were subtracted from all values.
Binding of [
3 H]HU-243 This assay was performed as described previously [8, 31] 
Sodium dodecyl sulfate^polyacrylamide gel electrophoresis and
Western immunoblotting COS-7 cells transfected with the various HA-tagged CB 2 cDNAs in 10 cm culture plates were harvested with cold PBS and spun down at 3000 rpm (at 4³C for 10 min), and the cell pellets were mixed with 100 Wl/plate of Laemmli sample bu¡er, sonicated and frozen at 320³C. Samples of 20 Wl were incubated for 5 min at 100³C with dithiothreitol (0.1 M ¢nal) prior to loading onto 1.5 mm thick 10% polyacrylamide gel. Following electrophoresis, proteins were blotted onto a nitrocellulose membrane and the blot blocked in PBS containing 5% fat-free milk and 0.5% Tween-20, followed by 1.5 h incubation with anti-HA monoclonal antibody (HA.11, Boehringer Mannheim) diluted 1:1000 in 5% fat-free milk and 0.5% Tween-20. Blots were washed three times with PBS containing 0.3% Tween-20 and incubated for 1 h with horseradish peroxidase-coupled rat anti-mouse antibodies (Jackson Immunoresearch Laboratories) diluted 1:20 000 in 5% fat-free milk plus 0.5% Tween-20. The blot was extensively washed and peroxidase activity was observed by the enhanced chemiluminescence technique (Amersham).
Data analysis
Data presented in the text and ¢gures are mean values þ S.E.M. Statistical analysis of the data was done using the Student's t-test. Dose^response curves were plotted using the Sigma Plot 4.11 program.
Results and discussion
There is evidence that the E/DRY sequence located at the junction of TM3 and ICL2 of many GPCRs has a role in various receptor functions, including receptor expression, constitutive receptor activation, G protein coupling, receptor sequestration and receptor internalization [11, 19, 20, 22, 23, 32] . However, the role of this motif in the signal transduction of the CB 2 receptor has not yet been examined. We have therefore mutated the CB 2 receptor (tagged with a HA epitope at its N-terminus) at this site, replacing either individual amino acids or all three of them with alanines, and examined the cannabinoid binding activity and the signal transduction capacity of the mutants versus HA-CB 2 (wt). HA-tagging of the CB 2 receptor did not a¡ect agonist binding, nor did it a¡ect the modulation of AC activity by cannabinoid agonists (data not shown). Fig. 2A shows that compared to HA-CB 2 (wt), the DRY130^132AAA mutant retained only 15% of the binding of the high a¤nity cannabinoid agonist [ 3 H]HU-243, and the D130A mutant retained about 20%. On the other hand, the R131A and Y132A mutants retained almost normal binding activity of 80% and 70% speci¢c binding, respectively. This implies that in CB 2 , the D130 residue seems to be involved in the binding activity of the receptor, while R131 and Y132 would appear to be less important for this function. Even though both DRY130^132AAA and D130A showed only little cannabinoid agonist binding, we tested their signaling capacity and found that their activation by either HU-210 or WIN55,212-2 did not lead to any signi¢cant AC inhibition (data not shown). Thus, these mutants also appear to be defective in their downstream signaling. Fig. 2B is a control experiment demonstrating by Western blot analysis that all the mutants used in this study are e¤-ciently expressed, and thus the reduction in binding to the D130A mutant is not due to reduced expression. The molecular weight observed for the major immunoreactive band was 41 kDa, which is consistent with the amino acid composition of the HA-tagged receptor and with the molecular weight obtained for the expressed human CB 2 receptor protein [33] .
Ligand binding to the CB 2 D130A mutant
This loss of binding by the D130A mutant, but not by the R131A mutant, in CB 2 is in agreement with the results obtained by others for the m 1 -muscarinic receptor [17, 21] . However, it should be noted that mutating the conserved D residue in the E/DRY motif led to di¡erent results with di¡erent receptors or receptor functions. A reduction in G protein coupling with retention of high a¤nity ligand binding was observed with L-and K 2 -adrenergic receptors [34, 35] . On the other hand, mutation of D122 in the m 1 -muscarinic receptor led to a decrease in the level of antagonist binding to the receptor (depending on the amino acid replaced), but it was claimed that the D122 residue does not directly participate in the signaling [17] . Moreover, mutation of the D residue was shown to promote constitutive receptor activation in rhodopsin [36] and in the K 1B -adrenergic receptor [19, 20] , but not in the m 1 -muscarinic receptor [17] .
Ligand binding and signaling by the CB 2 R131A mutant
Fig . 3A ,B shows the competitive binding curves for the cannabinoid agonists, HU-210 and WIN55,212-2, in COS cells transfected with cDNAs of either HA-CB 2 (wt) or the R131A mutant. The data show that HU-210 binds with a K i of 145 þ 51 pM and 234 þ 52 pM for HA-CB 2 (wt) and the R131A mutant, respectively. WIN55,212-2 binds with a K i of 1.0 þ 0.2 nM and 2.5 þ 0.3 nM for HA-CB 2 (wt) and the R131A mutant, respectively. Altogether, the R131A mutant binds well both HU-210 and WIN55,212-2, with a¤nities similar to those of wt receptor. It should be noted that the K i values of HU-210 and WIN55,212-2 binding to HA-CB 2 (wt) as found here are in agreement with previous data obtained by us and others for the binding to the CB 2 receptor: 220 þ 180 pM [37] , 147 þ 7 pM [38] and 170 þ 10 pM [31] for HU-210, and 280 þ 160 pM for WIN55,212-2 [37] .
This R residue was found to be absolutely conserved within all of the members of the GPCR family [11, 13] and its substitution in various GPCRs, such as the m 1 -muscarinic and K 1B -adrenergic receptors, severely reduced the agonist-induced activation of phosphoinositide hydrolysis [19, 21] . Oliveira et al. [11] suggested that this R residue serves as an Arg-switch, leading to activation of GPCRs (due to the shift of the charged side chain upon agonist activation, thereby modulating G protein coupling). Indeed, a combination of mutagenesis and computational simulations on K 1B -adrenergic and GnRH receptors showed the importance of this Arg in signaling [19, 32] .
We therefore analyzed the signaling of the R131A HA-CB 2 mutant in comparison with HA-CB 2 (wt). Fig. 3C ,D shows that G protein signaling by the R131A mutant is only weakly a¡ected, as the EC 50 values for the inhibition of transfected AC-V by WIN55,212-2 and by HU-210 were shifted to the right by less than 2-fold, in comparison to wt receptor. The EC 50 values for WIN55,212-2 were 1.34 þ 0.27 vs. 0.73 þ 0.2 nM, respectively, and for HU-210, 1.26 þ 0.03 vs. 0.78 þ 0.18 nM, respectively. The maximal levels of inhibition of AC-V by HU-210 and WIN55,212-2 with the R131A mutant were somewhat reduced compared with HA-CB 2 (wt): 30% vs. 55% and 50% vs. 60%, respectively. Interestingly, AC signaling by HU-210 was more a¡ected than by WIN55,212-2 in the R131A mutant. This di¡erence between HU-210 and WIN55,212-2 is not completely clear but could possibly be explained by the ¢nding that the binding site for classical cannabinoids (e.g. HU-210) is distinct from that for the aminoalkylindoles (e.g. WIN55,212-2) for both CB 1 and CB 2 receptors [39, 40] . Altogether, mutating R131 in CB 2 only slightly a¡ected signaling. This result di¡ers from the observation made with the m 1 -muscarinic, GnRH and K 1B -adrenergic receptors which, as described above, lost signaling capacity upon mutation of this site [17, 19, 32] .
Ligand binding and signaling by the CB 2 Y132A mutant
Relatively little is known about the role of the Y residue of the E/DRY motif in the GPCR superfamily. Replacing this residue with non-aromatic amino acids led to a reduction in the expression of the m 1 -muscarinic receptor binding sites, with minimal e¡ects on the signaling capability of the ligand binding receptors [17] . Fig. 4A ,B shows the competitive binding curves for HU-210 and WIN55,212-2 in COS cells transfected with HA-CB 2 (wt) or the Y131A mutant. The data show that agonist binding a¤nity is not a¡ected by this mutation. HU-210 binds with a K i of 145 þ 51 pM and 160 þ 41 pM for HA-CB 2 (wt) and the Y132A mutant, respectively. WIN55,212-2 binds with a K i of 1.0 þ 0.2 nM and 0.5 þ 0.2 nM for HA-CB 2 (wt) and the Y132A mutant, respectively. We next analyzed the signaling of the Y132A mutant. Fig. 4C ,D shows that the signaling by Y132A was markedly, but not completely, reduced. The maximal inhibitions by HU-210 and by WIN55,212-2 for the Y132A mutant were reduced as compared with HA-CB 2 (wt) (26% vs. 55% and 28% vs. 60%, respectively).
Reports regarding the role of this Y residue in signal transduction are controversial. Y3.51 was shown to have a role in the signaling and internalization of the bradykinin B2 receptor [22, 23] . However, as described above, mutating this residue in the m 1 -muscarinic receptor indicated that it is not critical for e¤cient signal transduction [17] . Moreover, converting the unique DRS sequence in the GnRH receptor to the conserved DRY sequence did not a¡ect receptor signaling [41] . Here, we show that mutating this residue partially, but not completely, interferes with receptor signaling.
In summary, the E/DRY motif at the junction of TM3 and ICL2 is highly conserved in most members of the GPCR superfamily. Whereas D130 in CB 2 seems to be related to receptor intramolecular contact a¡ecting ligand binding, Y132 appears to have a possible role in receptor downstream signaling.
